226
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Real-World Efficacy and Safety of Mycophenolate Mofetil in Active Moderate-to-Sight-Threatening Thyroid Eye Disease

, , & ORCID Icon
Pages 1921-1932 | Published online: 10 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jan Wolf, Kamila I. Mitka, Alicja Hubalewska-Dydejczyk, Irene Krämer & George J Kahaly. (2022) Drug safety in thyroid eye disease – a systematic review. Expert Opinion on Drug Safety 21:7, pages 881-912.
Read now
Wenwen Feng, Yifang Hu, Chengzhou Zhang, He Shi, Peng Zhang, Yanli Yang, Shiying Chen, Weijiang Cui & Dai Cui. (2022) Efficacy and safety of mycophenolate mofetil in the treatment of moderate to severe Graves’ orbitopathy: a meta-analysis. Bioengineered 13:6, pages 14719-14729.
Read now

Articles from other publishers (8)

M. Pelewicz-Sowa & P. Miśkiewicz. (2023) Dysthyroid optic neuropathy: emerging treatment strategies. Journal of Endocrinological Investigation 46:7, pages 1305-1316.
Crossref
Henry B Burch, Petros Perros, Tomasz Bednarczuk, David S Cooper, Peter J Dolman, Angela M Leung, Ilse Mombaerts, Mario Salvi & Marius N Stan. (2022) Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association. European Thyroid Journal 11:6.
Crossref
Henry B. Burch, Petros PerrosTomasz BednarczukDavid S. CooperPeter J. DolmanAngela M. Leung, Ilse MombaertsMario SalviMarius N. Stan. (2022) Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association. Thyroid 32:12, pages 1439-1470.
Crossref
Luigi Bartalena & Maria Laura Tanda. (2022) Current concepts regarding Graves’ orbitopathy. Journal of Internal Medicine 292:5, pages 692-716.
Crossref
Hongxun Li, Lihong Yang, Yi Song, Xinheng Zhao, Chunhua Sun, Lei Zhang, Hong Zhao & Ye Pan. (2021) Comparative effectiveness of different treatment modalities for active, moderate‐to‐severe Graves' orbitopathy: a systematic review and network meta‐analysis. Acta Ophthalmologica 100:6.
Crossref
Tracy J. Lu, Linus Amarikwa, Connie M. Sears & Andrea L. Kossler. (2022) Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy. Current Neurology and Neuroscience Reports 22:6, pages 313-325.
Crossref
Mohammad Taher Rajabi, Seyed Mohsen Rafizadeh, Abbas Mohammadi, Bahram Eshraghi, Nader Mohammadi, Seyedeh Simindokht Hosseini, Mohammad Bagher Rajabi, Mohammad Mohsen Keshmirshekan, Mansoor Shahriari, Seyedeh Zahra Poursayed Lazarjani & Mohammad Mehdi Parandin. (2022) Mycophenolate Mofetil (CellCept®) in Combination With Low Dose Prednisolone in Moderate to Severe Graves' Orbitopathy. Frontiers in Medicine 9.
Crossref
. (2022) Mycophenolate-mofetil. Reactions Weekly 1888:1, pages 282-282.
Crossref